40,005 Shares in Maximus, Inc. $MMS Purchased by Capital Fund Management S.A.

Key Points

• Capital Fund Management S.A. purchased 40,005 shares of Maximus, Inc. valued at approximately $2.73 million during the first quarter, holding about 0.07% of the company.
• Director Gayathri Rajan sold 7,913 shares of Maximus, reducing her position by 35.78%, with the sale totaling $572,742.94.
• Wall Street Zen recently downgraded Maximus from a "buy" to a "hold" rating, while the stock currently maintains an average target price of $90.00 according to analyst estimates.

Capital Fund Management S.A. bought a new position in Maximus, Inc. (NYSE:MMS - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 40,005 shares of the health services provider's stock, valued at approximately $2,728,000. Capital Fund Management S.A. owned 0.07% of Maximus at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Captrust Financial Advisors bought a new position in Maximus in the 4th quarter worth $276,000. GAMMA Investing LLC increased its holdings in shares of Maximus by 67.1% during the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider's stock worth $50,000 after purchasing an additional 294 shares during the period. Blue Trust Inc. increased its holdings in shares of Maximus by 32.8% during the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider's stock worth $84,000 after purchasing an additional 303 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of Maximus during the 1st quarter worth about $2,115,000. Finally, Janney Montgomery Scott LLC increased its holdings in shares of Maximus by 70.5% during the 1st quarter. Janney Montgomery Scott LLC now owns 10,145 shares of the health services provider's stock worth $692,000 after purchasing an additional 4,196 shares during the period. Institutional investors own 97.21% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on MMS shares. Zacks Research upgraded shares of Maximus from a "hold" rating to a "strong-buy" rating in a research report on Tuesday. Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Strong Buy" and an average target price of $90.00.

Maximus Stock Up 0.1%

Maximus stock traded up $0.10 during mid-day trading on Thursday, reaching $87.66. The company's stock had a trading volume of 552,291 shares, compared to its average volume of 571,881. The company has a market capitalization of $4.94 billion, a price-to-earnings ratio of 16.14 and a beta of 0.60. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.94. The business's 50 day simple moving average is $75.55 and its 200 day simple moving average is $71.38. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27.

Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.77. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm's revenue for the quarter was up 2.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.74 earnings per share. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be paid a $0.30 dividend. The ex-dividend date is Friday, August 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. Maximus's dividend payout ratio (DPR) is currently 22.10%.

Insider Buying and Selling

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the sale, the director owned 14,205 shares in the company, valued at $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by corporate insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.